Concepedia

Melvin R. White

MR

4

Publications

135

Citations

4

H-Index

2006

Active since

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Ireland)

University of Nebraska Medical Center

Melvin R. White is an author at Bristol-Myers Squibb (Germany) specializing in pharmacology, medicine, and urology.

Top concepts

UrologyMedicinePharmacologyOncologyCancer ResearchPharmacotherapyPhysiologyHuman GrowthUrogynecologyClinical Chemistry

Publications per year

2006–2020

4

Publications

4

Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action

Mark A. Dominick, Melvin R. White, Thomas P. Sanderson et al. · Toxicologic Pathology · 2006 · 92 citations · Full text

Molecular Pharmacology, Urological Research, Urology +14

Subchronic Urinary Bladder Effects of Muraglitazar in Male Rats1

Terry R. Van Vleet, Melvin R. White, Thomas P. Sanderson et al. · Toxicological Sciences · 2006 · 18 citations

Urological Research, Urology, Oncology +11

Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium

William E. Achanzar, Carolyn F. Moyer, Laura T. Marthaler et al. · Toxicology and Applied Pharmacology · 2007 · 13 citations

Urological Research, Urology, Molecular Physiology +9

Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS‐986260, mitigates class‐based cardiovascular toxicity in dogs but not rats

Gregory D. Rak, Melvin R. White, Karen Augustine‐Rauch et al. · Journal of Applied Toxicology · 2020 · 12 citations

Rows per page

1–4 of 4